Business Description
Meds Apotek AB (publ)
ISIN : SE0018014110
Total Employee Number:
49Compare
Compare
Traded in other countries / regions
MEDS.Sweden24R.Germany IPO Date
2023-03-02Description
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 15.13 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.35 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.15 | |||||
Beneish M-Score | -1.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | 6.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 68.73 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.07 | |||||
9-Day RSI | 43.52 | |||||
14-Day RSI | 43.16 | |||||
3-1 Month Momentum % | -24.18 | |||||
6-1 Month Momentum % | -56.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.47 | |||||
Days Inventory | 84.66 | |||||
Days Sales Outstanding | 12.71 | |||||
Days Payable | 77.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | 4.49 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.32 | |||||
Operating Margin % | -0.13 | |||||
Net Margin % | 1.2 | |||||
EBITDA Margin % | 1.75 | |||||
FCF Margin % | 0.07 | |||||
OCF Margin % | 1.27 | |||||
ROE % | 7.33 | |||||
ROA % | 3.34 | |||||
ROC (Joel Greenblatt) % | -1.42 | |||||
ROCE % | -0.45 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 46.59 | |||||
Forward PE Ratio | 10.54 | |||||
PE Ratio without NRI | 46.59 | |||||
PS Ratio | 0.49 | |||||
PB Ratio | 2.85 | |||||
Price-to-Tangible-Book | 3.23 | |||||
Price-to-Free-Cash-Flow | 66.99 | |||||
Price-to-Operating-Cash-Flow | 23.46 | |||||
EV-to-EBIT | -567.84 | |||||
EV-to-EBITDA | 24.24 | |||||
EV-to-Revenue | 0.42 | |||||
EV-to-FCF | 102.49 | |||||
Price-to-Graham-Number | 2.01 | |||||
| Price-to-Net-Current-Asset-Value | 4.31 | |||||
Earnings Yield (Greenblatt) % | -0.17 | |||||
FCF Yield % | 0.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Meds Apotek AB (publ) Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 99.031 | ||
| EPS (TTM) (€) | 0.069 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 43.16 | ||
| 14-Day ATR (€) | 0.070848 | ||
| 20-Day SMA (€) | 1.847 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.75 - 5.2 | ||
| Shares Outstanding (Mil) | 18.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Meds Apotek AB (publ) Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Meds Apotek AB (publ) Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 107 days | ||
| Second quarter earnings results for 2027 | 2026-09-30 | In 70 days | ||
| General meeting for 2026 | 2026-05-21 10:00 | 1.85 (-3.65%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 2.40 (-1.23%) | ||
| Annual report for 2026 | 2026-04-23 | 2.43 (-3.95%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-05 | 4.02 (-4.74%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 4.46 (+0.45%) |
Show
Entries
Meds Apotek AB (publ) Frequently Asked Questions
What is Meds Apotek AB (publ)(FRA:24R)'s stock price today?
The current price of FRA:24R is €1.81. The 52 week high of FRA:24R is €5.20 and 52 week low is €1.75.
When is next earnings date of Meds Apotek AB (publ)(FRA:24R)?
The next earnings date of Meds Apotek AB (publ)(FRA:24R) is 2026-09-30 Est..
Does Meds Apotek AB (publ)(FRA:24R) pay dividends? If so, how much?
Meds Apotek AB (publ)(FRA:24R) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Meds Apotek AB (publ)
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers